This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters to the Editor

Cessation of Self-Mutilation in a Patient With Borderline Personality Disorder Treated With Naltrexone

Michael D. McGee

Published: January 15, 1997

Article Abstract

Letter to the Editor

Sir: Self-mutilation and self-injurious behavior may be duein part to dysregulation of endorphin neurotransmitter systems.Self-mutilation and dissociation occur frequently inpatients with borderline personality disorder and associatedhistories of traumatic abuse and neglect, suggesting there maybe an etiologic relationship between trauma, neglect, endorphinsystem dysfunction, and self-mutilation. This hypothesis issupported by the observation that some patients with borderlinepersonality disorder have elevated pain thresholds, a phenomenonmediated in part by endorphin systems.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 58

Quick Links: Personality Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...